Company
CytoTerra
Next-generation cancer diagnostics from CytoTerra
Also known as CytoTerra Inc.
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Seattle, WA, United States
- Customers
- clinicians
- Legal name
- CytoTerra Inc.
Claim, correct or request removal
Record updated 19 October 2026
About
CytoTerra eliminates need for multiple cytogenetic tests with a single comprehensive assay.
Funding snapshot
- Total raised
- $1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $300K2026-09-25
Funding rounds
- Round, 2026
- $300K2026-09-25, SEC form D sold
- Round, 2026
- $1M2026-01-28, SEC form D sold, 13 investors
Loading relationship preview